Berman Capital Advisors’s ResMed RMD Stock Holding History

Berman Capital Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$142K	Buy	542 +133	+33%	+$36.4K	0.02%	347
2021 Q2	$100K	Buy	409 +30	+8%	+$6.31K	0.02%	381
2021 Q1	$73K	Buy	379 +121	+47%	+$24.3K	0.02%	369
2020 Q4	$54K	Sell	258 -36	-12%	-$7.18K	0.01%	393
2020 Q3	$49K	Buy	294 +50	+20%	+$9.23K	0.01%	350
2020 Q2	$46K	Buy	244 +29	+13%	+$4.75K	0.01%	341
2020 Q1	$30K	Buy	215 +21	+11%	+$3.35K	0.01%	395
2019 Q4	$30K	Hold	194	–	–	0.01%	433
2019 Q3	$26K	Buy	194 +10	+5%	+$1.31K	0.01%	439
2019 Q2	$22K	Buy	184 +68	+59%	+$7.53K	0.01%	490
2019 Q1	$12K	Buy	116 +50	+76%	+$5.16K	﹤0.01%	603
2018 Q4	$6K	Buy	+66	New	+$7.07K	﹤0.01%	644

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Berman Capital Advisors's RMD Position: Q3 2021 in Review

Berman Capital Advisors increased its ResMed (RMD) stake by 33% in Q3 2021, buying an estimated $36.4K and bringing the position to 542 shares worth $142K. The position accounts for 0.02% of the portfolio, ranked #347.

Berman Capital Advisors first reported a position in RMD in Q4 2018 and has held it in 12 quarters since. 687 funds tracked by Wall St. Rank hold RMD as of Q3 2021.

Berman Capital Advisors held 542 shares of ResMed worth $142K as of Q3 2021.
Berman Capital Advisors bought 133 ResMed shares in Q3 2021, an estimated $36.4K.
ResMed made up 0.02% of Berman Capital Advisors's portfolio in Q3 2021, its #347 holding.
Berman Capital Advisors first reported a position in ResMed in Q4 2018 and has held it in 12 quarters since.
687 funds tracked by Wall St. Rank held ResMed as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.